 |
PDBsum entry 3mpm
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.2.7.10.2
- non-specific protein-tyrosine kinase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
L-tyrosyl-[protein] + ATP = O-phospho-L-tyrosyl-[protein] + ADP + H+
|
 |
 |
 |
 |
 |
L-tyrosyl-[protein]
|
+
|
ATP
|
=
|
O-phospho-L-tyrosyl-[protein]
|
+
|
ADP
|
+
|
H(+)
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
|
Bioorg Med Chem Lett
20:3628-3631
(2010)
|
|
PubMed id:
|
|
|
|
|
| |
|
New pyrazolo[1,5a]pyrimidines as orally active inhibitors of Lck.
|
|
N.Gommermann,
P.Buehlmayer,
A.von Matt,
W.Breitenstein,
K.Masuya,
B.Pirard,
P.Furet,
S.W.Cowan-Jacob,
G.Weckbecker.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
A novel series of pyrazolo[1,5a]pyrimidines was optimized to target
lymphocyte-specific kinase (Lck). An efficient synthetic route was developed and
SAR studies toward activity and selectivity are described, leading to Lck
inhibitors with enzymatic, cellular and in vivo potency.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
');
}
}
 |